Ozempic and GLP-1 Drugs: Risks, Trends, and Effectiveness in Weight Loss
TL;DR
Ozempic, a popular drug for weight loss and diabetes, is facing numerous lawsuits due to alleged severe side effects, especially irreversible vision loss from NAION, with regulatory bodies and studies supporting a potential link. The legal battle is intensifying, with significant financial and reputational risks for Novo Nordisk, as plaintiffs share personal stories and courts consider the evidence. The outcome could reshape pharmaceutical accountability and drug safety standards.
- Ozempic Lawsuit: Everything You Need To Know About The Latest Vision Loss Allegations Bored Panda
- Ozempic trend: 1 in 10 Americans have tried weight loss drugs— here’s why 74% still say ‘not for me' The Times of India
- 22 Investigates: Potential dangers of GLP-1 medications WSBT
- Weight-loss jabs are not enough to tackle the obesity crisis, experts warn Yahoo News UK
- What does the latest research say about the benefits of GLP-1 drugs? - Transcript CBC
Want the full story? Read the original reporting
Read on Bored Panda